<DOC>
	<DOCNO>NCT02481258</DOCNO>
	<brief_summary>The primary objective current study determine whether Ataciguat ( HMR1766 ) slow progression valve calcification patient moderate calcific aortic valve stenosis . Secondary tertiary objective determine whether Ataciguat slow progression aortic valve function , reduce systemic inflammation , prevents leave ventricular dysfunction patient moderate calcific aortic valve stenosis .</brief_summary>
	<brief_title>A Study Evaluating Effects Ataciguat ( HMR1766 ) Aortic Valve Calcification</brief_title>
	<detailed_description>Patients Moderate Calcific Aortic Valve Stenosis may eligible enrollment study . Participation last 12 month , include total 3 study visit ( baseline/screening visit , 6 month follow visit 12 month follow visit ) . During visit , blood sample take along research relate test ( Orthostatic Tolerance Standing Test , CT Scan , Echocardiogram , DEXA Scan ) . Qualifying Participants supply 6 month worth study medication placebo visit 1 ( baseline/screening visit ) 2 ( 6 month follow visit ) take home daily food . On visit 3 ( 12 month follow visit ) , remain study medication placebo return study staff .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Inclusion Criteria 1 . Age &gt; 50 year 2 . Male female sex 3 . Aortic valve area great 1.0 cm2 less 2.0 cm2 4 . Aortic valve calcium level great 300 AU chest CT 5 . Ejection fraction &gt; 50 % Exclusion Criteria 1 . Orthostatic intolerance symptomatic hypotension prior study study visit 2 . Positive pregnancy test screen visit 3 . Nitrate use αantagonist medication use within 24 hour 4 . Systolic blood pressure &lt; 110 mm Hg 5 . Mean systemic arterial pressure &lt; 75 mm Hg 6 . Severe mitral aortic regurgitation 7 . Retinal optic nerve problem 8 . Recent ( ≤30 day ) acute coronary syndrome 9 . Oxygen saturation &lt; 90 % room air 10 . Congenital valve disease 11 . Hepatic dysfunction/elevated liver enzymes 12 . Prescription drug know alter NOsGCcGMP signal ( sildenafil , nitrate , etc . ) 13 . Prescription Warfarin ( Coumadin ) chronic anticoagulation 14 . Concomitant participation trial Mayo Clinic elsewhere 15 . Use phenytoin related compound indication 16 . Chronic midazolam treatment indication 17 . Use monoamine oxidase inhibitor indication 18 . Use antidiabetic drug sulfonylurea family</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Stenosis</keyword>
	<keyword>Aortic Valve</keyword>
	<keyword>Aorta</keyword>
	<keyword>Calcified</keyword>
	<keyword>Calcific</keyword>
	<keyword>Calcification</keyword>
</DOC>